Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nanocurcumin in Ankylosing Spondylitis
NCT03140657Phase 2Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Apr 2017
- Primary completion
- Nov 2017
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nanocurcumin in ankylosing spondylitis (AS), sponsored by Tabriz University of Medical Sciences. Started Apr 2017; status: completed.
02
Drugs
nanocurcumin
03
Conditions
ankylosing spondylitis (AS)
Beyond the preview
Go deeper on NCT03140657.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03140657.